clinical

Cheryl Guttman is a medical writer based in Deerfield, Ill.

Articles

The hope is that future analyses would show more patients completing the pathway and a lower rate of missed appointments.



Pilot pregnancy pathway addresses challenges of diabetic retinopathy screening

Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.

The development of a novel AI-based algorithm aims to improve risk prediction for diabetic eye disease.



From ETDRS to EviRed: Eyeing a new artificial intelligence-based algorithm

Insights into the pathophysiology of diabetic macular edema are providing a basis for therapeutic interventions.


DME strategies directed by knowledge of mechanisms 

Multiple challenges remain for diabetic macular edema with unmet needs to improve treatment outcomes, speed of treatment benefit, and the duration of response.



What an intravitreal integrin antagonist may bring to DME

Three risk-related baseline factors identified by this analysis may be associated with a potential need for injections.

Post hoc analysis: Protocol V provides more practical DME guidance for clinicians

A study including data from about 42,000 eyes found diabetic retinopathy (DR) severity is a risk factor for the progression of diabetic eye disease. Other findings support the idea that genetic factors influence the development of proliferative DR versus diabetic macular edema. 



Research suggests course of diabetic eye disease influenced by genetic factors

Study highlights the role of demographic and socioeconomic characteristics as contributors to disease- and treatment-related disparities among patients with diabetic macular edema.

Identifying gaps in anti-VEGF treatment among minorities with DME

Podcasts

Ehsan Rahimy, MD, speaks on the highlights of a study he presented at this year's virtual AAO 2020 meeting that aimed to integrate an artificial intelligence screening system for managing diabetic retinopathy referrals in a primary care setting — with limited specialty support.

Integrating AI to manage DR in a primary care setting

Videos

A panel of experts in ophthalmology and optometry review the diagnosis and treatment of diabetic eye disease including emerging agents in the field.

Updates in DME, diabetic retinopathy

Results support further research investigating transforming growth factor-β-Induced Gene Human Clone 30 (BIGH3).

Diabetic Retinopathy